comparemela.com

Latest Breaking News On - Cardiology transcatheter valve therapy - Page 1 : comparemela.com

Repeat transcatheter aortic valve replacement after initial attempt is generally safe in patients with balloon-expandable valves

1. Redo-TAVR had low procedural complication rates and was comparable to native-TAVR in terms of risk of death and stroke at 30 days and 1 year. 2. Rates of moderate-to-severe aortic regurgitation were comparable between groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Transcatheter aortic valve replacement (TAVR) has become a standard treatment for aortic

Rating levelTranscatheter aortic valve replacementLow risk patientsAmerican collegeCardiology transcatheter valve therapyAortic regurgitationAortic stenosisAortic valveAortic valve repairCardiac surgeryChronic disease

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

In practice, patients are a little sicker and are not receiving GDMT, which is a problem, believes one HF expert.

New yorkUnited statesMathias orbanMitraclip abbottCardiovasculaire louis pradelNathan mewtonKashish goelMd vanderbilt university medical centerDrug administrationJournal of the american college cardiologyApproval studyVanderbilt university medical centerGregg stoneIcahn schoolMount sinaiMedizinische klinik

Redo TAVR procedures are safe and effective, study shows

Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.

United statesEduardo marbMegan craigRaj makkarStephenr cordaySmidt heart institute at cedarsInterventional cardiology divisionMark siegel family foundation distinguished professorSmidt heart instituteDepartment of cardiologyCardiovascular innovationAmerican collegeCardiology transcatheter valve therapyMark siegel family foundation distinguishedTranscatheter aortic valve replacementInterventional cardiology

Primary TAVR may be best strategy for aortic stenosis causing cardiogenic shock

Data suggest transcatheter aortic valve replacement with a balloon-expandable valve is an acceptable and safe treatment for patients with aortic stenosis and cardiogenic shock, researchers reported.Compared with patients with aortic stenosis who underwent TAVR and had no cardiogenic shock, those with aortic stenosis and cardiogenic shock who underwent TAVR had worse outcomes in-hospital and at 30

France generalUnited statesByregina schafferRichard smithAbhijeet dhobleEdwards lifesciencesMcgovern medical schoolBoston scientificAbbott vascularTexas health science centerAmerican collegeCardiology transcatheter valve therapyKansas city cardiomyopathy questionnaire

Redo TAVR may be reasonable option for failed transcatheter heart valves

Patients who underwent a second transcatheter aortic valve replacement were no more likely to experience adverse in-hospital, 30-day and 1-year outcomes than those after a first TAVR, according to an analysis of real-world registry data.With the expansion of TAVR indications to younger populations, more patients will need a repeat aortic valve replacement in their lifetime, Raj R. Makkar, MD,

United statesFrance generalEdwards lifesciencesRichard smithRajr makkarByregina schafferBoston scientificSmidt heart instituteAdobe stockAmerican collegeCardiology transcatheter valve therapy

vimarsana © 2020. All Rights Reserved.